Skip to main content

Table 2 Pathogens and contribution of different methods to microbiological diagnosis

From: Invasive and non-invasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia

 

Entire cohort

(n = 200)

Never received invasive MV after HAP

(n = 78)

Received invasive MV after HAP

(n = 122)

P value

Definitive causative pathogen

99 (50%)

31 (40%)

68 (56%)

0.027

 Gram negative non-fermenting bacteria

39/99 (39%)

11/31 (35%)

28/68 (41%)

0.59

  Pseudomonas aeruginosa

30/99 (30%)

10/31 (32%)

20/68 (29%)

0.78

S. aureus

24/99 (24%)

6/31 (19%)

18/68 (27%)

0.44

  MSSA

15/99 (15%)

4/31 (13%)

11/68 (16%)

0.77

  MRSA

9/99 (9%)

2/31 (7%)

7/68 (10%)

0.72

 Gram negative enteric bacteria

24/99 (24%)

8/31 (26%)

16/68 (24%)

0.81

 Community pathogens (S. pneumococcus, Haemophylus influenzae)

9/99 (9%)

3/31 (10%)

6/68 (9%)

> 0.99

 Virus

3/99 (3%)

3/68 (4%)

0.55

 Other

9/99 (9%)

1/31 (3%)

8/68 (12%)

0.27

Polymicrobial

17/99 (17%)

3/31 (10%)

14/68 (21%)

0.182

Multi-drug resistant

40/99 (40%)

12/31 (39%)

28/68 (41%)

0.82

Microbiological diagnosis by

 Sputum

23/99 (23%)

11/31 (36%)

12/68 (18%)

0.051

 EAT

27/99 (27%)

27/68 (40%)

< 0.001

 FBAS

46/99 (47%)

15/31 (48%)

31/68 (46%)

0.80

 BAL

18/99 (18%)

2/31 (7%)

16/68 (24%)

0.041

 Pleural fluid

6/99 (6%)

6/68 (9%)

0.051

 Urinary antigen

5/99 (5%)

3/31 (10%)

2/68 (3%)

0.175

 Blood culture

14/99 (14%)

4/31 (13%)

10/68 (15%)

> 0.99

Microbiological diagnosis by

 1 method

69/99 (70%)

27/31 (87%)

42/68 (62%)

0.015

 2 methods

20/99 (20%)

4/31 (13%)

16/68 (23%)

 3 methods

10/99 (10%)

10/68 (15%)

Microbiological diagnosis uniquely defined by 1 method

 Sputum

10/69 (15%)

9/27 (33%)

1/42 (2%)

0.001

 EAT

16/69 (23%)

16/42 (38%)

< 0.001

 FBAS

29/69 (42%)

12/27 (44%)

17/42 (41%)

0.81

 BAL

6/69 (9%)

6/42 (14%)

0.075

 Pleural fluid

 Urinary antigen

3/69 (4%)

3/27 (11%)

0.056

 Blood culture

5/69 (7%)

3/27 (11%)

2/42 (5%)

0.37

  1. BAL bronchoalveolar lavage, EAT endotracheal aspirate, FBS fiberoptic bronchoscopy, FBAS fiberoptic-bronchoscopy aspirate, HAP hospital-acquired pneumonia, iMV invasive mechanical ventilation